摘要: The evolution of breast cancer is likely to be promoted by estrogen acting together with other hormones [1]. Since promotion steps in development are often reversible, it has been proposed that the progression may suppressed giving an antiestrogen for a prolonged period.
springer.com
sci-hub.st 参考文章(35)
, Effects of Adjuvant Tamoxifen and of Cytotoxic Therapy on Mortality in Early Breast Cancer New England Journal of Medicine. ,vol. 319, pp. 1681- 1692 ,(1988) , 10.1056/NEJM198812293192601
Scottish Cancer Trials Office, Adjuvant tamoxifen in the management of operable breast cancer : Scottish Trial The Lancet. ,vol. 2, pp. 171- 175 ,(1987)
Gottardis Mm, Jordan Vc, Antitumor Actions of Keoxifene and Tamoxifen in the N-Nitrosomethylurea-induced Rat Mammary Carcinoma Model Cancer Research. ,vol. 47, pp. 4020- 4024 ,(1987)
J. Cuzick, D. Allen, M. Baum, J. Barrett, G. Clark, V. Kakkar, E. Melissari, C. Moniz, J. Moore, V. Parsons, K. Pemberton, P. Pitt, W. Richmond, J. Houghton, D. Riley, Long term effects of tamoxifen: Biological Effects of Tamoxifen Working Party European Journal of Cancer. ,vol. 29, pp. 15- 21 ,(1993) , 10.1016/0959-8049(93)90568-Z
Roger W. Blamey, Mitchell Dowsett, Michael Baum, Nigel J. Bundred, Alan E. Wakeling, Christobel Saunders, Anthony Howell, Robert I. Nicholson, Elizabeth Anderson, John F. Robertson, Robert E. Mansel, Frances Sutcliffe, David J. DeFriend, Peter Walton, Investigation of a New Pure Antiestrogen (ICI 182780) in Women with Primary Breast Cancer Cancer Research. ,vol. 54, pp. 408- 414 ,(1994)
A. H. Paterson, P. H. Geggie, Can tamoxifen prevent breast cancer Canadian Medical Association Journal. ,vol. 148, pp. 141- 144 ,(1993)
M C Sunderland, C K Osborne, Tamoxifen in premenopausal patients with metastatic breast cancer: a review. Journal of Clinical Oncology. ,vol. 9, pp. 1283- 1297 ,(1991) , 10.1200/JCO.1991.9.7.1283
Nicholas A. Pavlidis, Christos Petris, Evagellos Briassoulis, George Klouvas, Constantine Psilas, John Rempapis, George Petroutsos, Clear evidence that long-term, low-dose tamoxifen treatment can induce ocular toxicity. A prospective study of 63 patients. Cancer. ,vol. 69, pp. 2961- 2964 ,(1992) , 10.1002/1097-0142(19920615)69:12<2961::AID-CNCR2820691215>3.0.CO;2-W
B. Fisher, C. Redmond, New perspective on cancer of the contralateral breast: a marker for assessing tamoxifen as a preventive agent. Journal of the National Cancer Institute. ,vol. 83, pp. 1278- 1281 ,(1991) , 10.1093/JNCI/83.18.1278
Bernard Fisher, Joseph Costantino, Carol Redmond, Roger Poisson, David Bowman, Jean Couture, Nikolay V Dimitrov, Norman Wolmark, D Lawrence Wickerham, Edwin R Fisher, Richard Margolese, Andre Robidoux, Henry Shibata, Jose Terz, AHG Paterson, Merrill I Feldman, William Farrar, James Evans, H Lavina Lickley, Mary Ketner, *, None, A Randomized Clinical Trial Evaluating Tamoxifen in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor–Positive Tumors New England Journal of Medicine. ,vol. 320, pp. 479- 484 ,(1989) , 10.1056/NEJM198902233200802